Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsored by: |
Eli Lilly and Company |
---|---|
Information provided by: | Eli Lilly and Company |
ClinicalTrials.gov Identifier: | NCT00479414 |
To assess the effectiveness of duloxetine administered once daily in patients with Major Depressive Disorder in a practice-based setting
Condition | Intervention | Phase |
---|---|---|
Major Depressive Disorder |
Drug: Duloxetine hydrochloride |
Phase IV |
Study Type: | Interventional |
Study Design: | Treatment, Non-Randomized, Open Label, Uncontrolled, Single Group Assignment, Safety/Efficacy Study |
Official Title: | Lilly's Emotional and Physical Symptoms of Depression Study |
Estimated Enrollment: | 8000 |
Study Start Date: | August 2004 |
Study Completion Date: | January 2005 |
To assess physical and emotional symptoms of depressed patients
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
United States, Indiana | |
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM - 5 PM Eastern Time (UTC/GMT - 5 hours), or speak with your personal physician. | |
Indianapolis, Indiana, United States |
Study Director: | Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 9AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST) | Eli Lilly and Company |
Study ID Numbers: | 7442, F1J-MC-HMCM |
Study First Received: | May 25, 2007 |
Last Updated: | May 25, 2007 |
ClinicalTrials.gov Identifier: | NCT00479414 History of Changes |
Health Authority: | United States: Institutional Review Board |
Dopamine Uptake Inhibitors Neurotransmitter Agents Depression Adrenergic Agents Psychotropic Drugs Depressive Disorder, Major Depressive Disorder Serotonin Uptake Inhibitors |
Duloxetine Serotonin Behavioral Symptoms Dopamine Mental Disorders Mood Disorders Dopamine Agents Antidepressive Agents |
Dopamine Uptake Inhibitors Neurotransmitter Uptake Inhibitors Neurotransmitter Agents Depression Adrenergic Agents Molecular Mechanisms of Pharmacological Action Adrenergic Uptake Inhibitors Physiological Effects of Drugs Psychotropic Drugs Depressive Disorder, Major Depressive Disorder |
Serotonin Uptake Inhibitors Duloxetine Pharmacologic Actions Behavioral Symptoms Serotonin Agents Mental Disorders Therapeutic Uses Mood Disorders Dopamine Agents Central Nervous System Agents Antidepressive Agents |